Post by PressRelease on Nov 20, 2024 4:30pm
New Press Release - Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
Comment by
Pandora on Nov 20, 2024 4:43pm
A positive article. Will it move the needle? I sure hope so -- I could use a positive move somewhere, anywhere! I am sick and tired of my stocks being sick and tired.
Comment by
tylerreddick on Nov 20, 2024 5:57pm
“We are actively advancing discussions with potential commercial partners" If Howie ever gets a backer, we will be off to the races. But it should have already been done by now. And wasn't GlycoProtMim just an interm name? I thought we were supposed to get something a little more catchy?
Comment by
lscfa on Nov 20, 2024 7:53pm
This is not news. Results were disclosed in April 2023. Where the hell are the results of trials with Sirona Labs formulations which Geraldine said would be done in H2 2024? https://stockhouse.com/news/press-releases/2023/04/25/sirona-biochem-announces-exceptional-clinical-trial-results-for-anti-aging
Comment by
tylerreddick on Nov 20, 2024 10:36pm
To be fair, this news release was about the publication of the findings in the mentioned Journal. They didn't say it was a new study. Any public exposure is a good thing as we wait for funding.